Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off in AI safety prediction, generative chemistry, and faster translation.
Novartis’s Christian Diehl on scaling AI beyond the demo
calendar_today
September 27, 2026
domain
mckinsey-and-company